- Home
- STAA vs CII Comparison
STAA vs CII Comparison
Compare STAA & CII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STAA
- CII
- Stock Information
- Founded
- STAA 1982
- CII 2004
- Country
- STAA United States
- CII United States
- Employees
- STAA 1211
- CII N/A
- Industry
- STAA Ophthalmic Goods
- CII Investment Bankers/Brokers/Service
- Sector
- STAA Health Care
- CII Finance
- Exchange
- STAA Nasdaq
- CII Nasdaq
- Market Cap
- STAA 850.9M
- CII 870.4M
- IPO Year
- STAA N/A
- CII N/A
- Fundamental
- Price
- STAA $17.07
- CII $21.35
- Analyst Decision
- STAA Hold
- CII
- Analyst Count
- STAA 8
- CII 0
- Target Price
- STAA $27.17
- CII N/A
- AVG Volume (30 Days)
- STAA 817.0K
- CII 78.8K
- Earning Date
- STAA 08-06-2025
- CII 01-01-0001
- Dividend Yield
- STAA N/A
- CII 6.17%
- EPS Growth
- STAA N/A
- CII N/A
- EPS
- STAA N/A
- CII N/A
- Revenue
- STAA $279,134,000.00
- CII N/A
- Revenue This Year
- STAA N/A
- CII N/A
- Revenue Next Year
- STAA $29.34
- CII N/A
- P/E Ratio
- STAA N/A
- CII N/A
- Revenue Growth
- STAA N/A
- CII N/A
- 52 Week Low
- STAA $13.50
- CII $16.76
- 52 Week High
- STAA $49.86
- CII $19.81
- Technical
- Relative Strength Index (RSI)
- STAA 43.92
- CII 77.30
- Support Level
- STAA $16.53
- CII $20.27
- Resistance Level
- STAA $17.31
- CII $20.62
- Average True Range (ATR)
- STAA 0.63
- CII 0.18
- MACD
- STAA 0.01
- CII 0.03
- Stochastic Oscillator
- STAA 22.30
- CII 100.00
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of its sales are generated from the ophthalmic surgical product segment.
About CII Blackrock Capital and Income Fund Inc.
Blackrock Enhanced Cap&Inc Fund, Inc is a closed-end management investment company. Its objective is to provide total return through a combination of current income and capital appreciation. The trust seeks to achieve its investment objective by investing a majority of its total assets in a portfolio of equity securities of U.S. and foreign issuers.